Nab-paclitaxel Combined with Cadonilimab (AK104) As Second-Line Treatment for Advanced Gastric Cancer: Protocol for a Phase II Prospective, Multicenter, Single-Arm Clinical Trial
Frontiers in immunology（2025）
Key words
gastric cancer,cadonilimab (AK104),nab-paclitaxel,immunotherapy,phase II clinical trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined